Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 4:15:1-12.
doi: 10.2147/JAA.S321017. eCollection 2022.

Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region

Mona Al-Ahmad  1 , Saad Alsaleh  2 , Heba Al-Reefy  3 , Janan Al Abduwani  4 , Iman Nasr  5 , Rashid Al Abri  6 , Ahmed Mohd Haider Alamadi  7 , Ayman Ali Fraihat  8 , Abdulmohsen Alterki  9 , Mohamed Abuzakouk  10 , Osama Marglani  11 , Hussain Al Rand  12
Affiliations
Review

Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region

Mona Al-Ahmad et al. J Asthma Allergy. .

Abstract

Chronic rhinosinusitis (CRS) is defined as the inflammation of nose and paranasal sinuses, affecting the patients' quality of life and productivity. Chronic rhinosinusitis with nasal polyps (CRSwNP) is a principal clinical entity confirmed by the existence of chronic sinonasal inflammation and is characterized by anterior or posterior rhinorrhea, nasal congestion, hyposmia and/or facial pressure or facial pain. Several epidemiologic studies have revealed wide variations in the incidence of CRS among regions globally ranging from 4.6% to 12%. The Gulf countries are also witnessing an unprecedented burden of CRSwNP. According to the current clinical guidelines, glucocorticosteroids and antibiotics are the principal pharmacotherapeutic approaches. Endoscopic sinus surgery is recommended for those who have failed maximal pharmacotherapy. Recently, biologics are considered as an alternative best approach due to the complications associated with medical therapy and surgery. However, precise data on the clinical position of biologic agents in the management of CRSwNP in the Gulf region is not available. The present review article addresses the current diagnostic and management approaches for CRSwNP and also emphasizes the role of emerging biologics in the current treatment strategies for CRSwNP in the Gulf region. Further, a consensus protocol was convened to rationalize the guideline recommendations, strategize the best practices with biologics, and develop clinical practice guidelines for all primary-care specialists in the Gulf region. The consensus-based report will be a useful reference tool for primary-care physicians in primary-healthcare settings, regarding the appropriate time for the initiation of biological treatment in the Gulf region.

Keywords: endoscopic sinus surgery; glucocorticosteroids; inflammation; paranasal sinuses; rhinorrhea.

PubMed Disclaimer

Conflict of interest statement

Sanofi Genzyme has provided advisory board honoraria for authors who participated in Sanofi Genzyme advisory board, but they were not paid for writing the publication. The authors report no other potential conflicts of interest for this work.

Figures

Figure 1
Figure 1
Flow chart representation of consensus development.
Figure 2
Figure 2
Algorithm for the biological treatment in CRSwNP patients.
See this image and copyright information in PMC

References

    1. Chan Y, Kuhn FA. An update on the classifications, diagnosis, and treatment of rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2009;17(3):204–208. doi:10.1097/MOO.0b013e32832ac393 - DOI - PubMed
    1. Poddighe D, Brambilla I, Amelia L, et al. Pediatric rhinosinusitis and asthma. Respir Med. 2018;141:94–99. doi:10.1016/j.rmed.2018.06.016 - DOI - PubMed
    1. Nakayama T, Yoshikawa M, Asaka D, et al. Mucosal eosinophilia and recurrence of nasal polyps -new classification of chronic rhinosinusitis. Rhinology. 2011;49:392–396. doi:10.4193/Rhino10.261 - DOI - PubMed
    1. Slovick LJ, Hopkins C. Updates in the management of chronic rhinosinusitis. Clin Pract. 2014;11:649. doi:10.2217/cpr.14.71 - DOI
    1. Hussein A, Obaid A, Lotfi WT, et al. Prevalence, demographic and environmental factors of allergic fungal sinusitis among chronic sinusitis patients with nasal polyps in western Saudi Arabia. Pan Arab J Rhinol. 2019;9:26–30.